Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Mary L. Gemignani

ResearcherPublications, citations & collaboration network

Mary L. Gemignani is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 205 works, 6,642 citations, an h-index of 45 and an i10-index of 89.

205
Works
6,642
Citations
45
h-index
89
i10-index

How has Mary L. Gemignani's publication output changed over time?

ScholarIQpublication output · 1999–2023

Output grew0% over the shown period — from 1 works in 1999 to 1 in 2023.

1
1
2
2
1
1
1
1
1
199920022003200420052009201520162023

What are the most-cited papers on Mary L. Gemignani?

ScholarIQmost cited works
The Risk of Axillary Relapse After Sentinel Lymph Node Biopsy for Breast Cancer Is Comparable With That of Axillary Lymph Node Dissection
Arpana Naik, Jane V. Fey, Mary L. Gemignani, Alexandra S. Heerdt, Leslie L. Montgomery, Jeanne A. Petrek, Elisa Port, Virgilio Sacchini, Lisa M. Sclafani, Kimberly VanZee, Raquel Wagman, Patrick I. Borgen, Hiram S. Cody
Annals of Surgery. 2004400 CitationsOPEN ACCESS
How Often Does Neoadjuvant Chemotherapy Avoid Axillary Dissection in Patients With Histologically Confirmed Nodal Metastases? Results of a Prospective Study
Anita Mamtani, Andrea V. Barrio, Tari A. King, Kimberly J. Van Zee, George Plitas, Melissa Pilewskie, Mahmoud El‐Tamer, Mary L. Gemignani, Alexandra S. Heerdt, Lisa M. Sclafani, Virgilio Sacchini, Hiram S. Cody, Sujata Patil, Monica Morrow
Annals of Surgical Oncology. 2016309 Citations
Sentinel lymph node mapping for grade 1 endometrial cancer: Is it the answer to the surgical staging dilemma?
Nadeem R. Abu‐Rustum, Fady Khoury‐Collado, Neeta Pandit‐Taskar, Robert A. Soslow, Fanny Dao, Yukio Sonoda, Douglas A. Levine, Carol L. Brown, S. Dennis, Richard R. Barakat, Mary L. Gemignani
Gynecologic Oncology. 2009219 CitationsOPEN ACCESS
Role of KRAS and BRAF gene mutations in mucinous ovarian carcinoma
Mary L. Gemignani, Alan C. Schlaerth, Faina Bogomolniy, Richard R. Barakat, Oscar Lin, Robert A. Soslow, Ennapandam Venkatraman, Jeff Boyd
Gynecologic Oncology. 2003214 Citations
Isosulfan Blue Dye Reactions During Sentinel Lymph Node Mapping for Breast Cancer
Leslie L. Montgomery, Alisa C. Thorne, Kimberly J. Van Zee, Jane V. Fey, Alexandra S. Heerdt, Mary L. Gemignani, Elisa Port, Jeanne A. Petrek, Hiram S. Cody, Patrick I. Borgen
Anesthesia & Analgesia. 2002207 Citations

Related on ScholarIQ

Memorial Sloan Kettering Cancer Center
Institution
The Risk of Axillary Relapse After Sentinel Lymph Node Biopsy for Breast Cancer Is Comparable With That of Axillary Lymph Node Dissection
Paper
How Often Does Neoadjuvant Chemotherapy Avoid Axillary Dissection in Patients With Histologically Confirmed Nodal Metastases? Results of a Prospective Study
Paper
Sentinel lymph node mapping for grade 1 endometrial cancer: Is it the answer to the surgical staging dilemma?
Paper
Role of KRAS and BRAF gene mutations in mucinous ovarian carcinoma
Paper
Isosulfan Blue Dye Reactions During Sentinel Lymph Node Mapping for Breast Cancer
Paper
470M+ articles · free account